Therapeutics And Clinical Risk Management

Therapeutics And Clinical Risk Management英文簡(jiǎn)介

Therapeutics and Clinical Risk Management is an international, peer-reviewed journal of clinical therapeutics and risk management, focusing on concise rapid reporting of clinical studies in all therapeutic areas, outcomes, safety, and programs for the effective, safe, and sustained use of medicines, therapeutic and surgical interventions in all clinical areas.

The journal welcomes submissions covering original research, clinical and epidemiological studies, reviews, guidelines, expert opinion and commentary. The journal will consider case reports but only if they make a valuable and original contribution to the literature.

As of 18th March 2019, Therapeutics and Clinical Risk Management will no longer consider meta-analyses for publication.

The journal does not accept study protocols, animal-based or cell line-based studies.

Therapeutics And Clinical Risk Management中文簡(jiǎn)介

《Therapeutics And Clinical Risk Management》是一本由Dove Medical Press Ltd.出版商出版的專業(yè)醫(yī)學(xué)期刊，該刊創(chuàng)刊于2005年，刊期1 issue/year，該刊已被國(guó)際權(quán)威數(shù)據(jù)庫(kù)SCIE收錄。在中科院最新升級(jí)版分區(qū)表中，該刊分區(qū)信息為大類學(xué)科：醫(yī)學(xué) 4區(qū)，小類學(xué)科：衛(wèi)生保健與服務(wù) 4區(qū)；在JCR（Journal Citation Reports）分區(qū)等級(jí)為Q3。該刊發(fā)文范圍涵蓋衛(wèi)生保健與服務(wù)等領(lǐng)域，旨在及時(shí)、準(zhǔn)確、全面地報(bào)道國(guó)內(nèi)外衛(wèi)生保健與服務(wù)工作者在該領(lǐng)域取得的最新研究成果、工作進(jìn)展及學(xué)術(shù)動(dòng)態(tài)、技術(shù)革新等，促進(jìn)學(xué)術(shù)交流，鼓勵(lì)學(xué)術(shù)創(chuàng)新。2021年影響因子為2.755，平均審稿速度16 Weeks。

中科院分區(qū)最新升級(jí)版（當(dāng)前數(shù)據(jù)版本：2021年12月最新升級(jí)版）

大類學(xué)科	分區(qū)	小類學(xué)科	分區(qū)	Top期刊	綜述期刊
醫(yī)學(xué)	4區(qū)	HEALTH CARE SCIENCES & SERVICES 衛(wèi)生保健與服務(wù)	4區(qū)	否	否

JCR分區(qū)（當(dāng)前數(shù)據(jù)版本：2021-2022年最新版）

JCR分區(qū)等級(jí)	JCR所屬學(xué)科	分區(qū)	影響因子
Q3	HEALTH CARE SCIENCES & SERVICES	Q3	2.755

期刊指數(shù)

影響因子	h-index	Gold OA文章占比	研究類文章占比	OA開(kāi)放訪問(wèn)	平均審稿速度
2.755	43	96.77%	78.40%	開(kāi)放	16 Weeks

IF值(影響因子)趨勢(shì)圖